Definitive Contract W911QY19C0010
Award Date 10/15/18
Potential Completion Date 4/14/19
Potential Value $150K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
Total Small Business
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Zymeron Corporation, a minority-owned, for-profit biotechnology company, under the Small Business Innovation Research (SBIR) Program Phase I. The contract, valued at $197,000.00, is for research and development services related to an unspecified biomedical or public health initiative. As a total small business set-aside, this award aligns with Zymeron's...
- This contract was awarded by the Department of the Army Materiel Command TACOM Life Cycle Management Command to Zymeron Corporation, a minority-owned small business. The contract is for Phase I SBIR (Small Business Innovation Research) research, with a firm fixed-price contract type and a potential value of $162,482.83. Zymeron is a biotechnology company that focuses on developing innovative technologies in areas such as protein degradation, antibacterials, antivirals, and drug delivery systems....
- This contract is a $249,999.09 Small Business Innovation Research (SBIR) Phase I award from the Department of the Army Medical Command to Zymeron Corporation, a minority-owned biotechnology company based in Research Triangle Park, North Carolina. The award supports the research and development of a "Novel Antibiotic Targeting Multidrug-Resistant Pseudomonas Aeruginosa Infections." As a prime contractor, Zymeron has experience providing medical research, engineering services, IT...
- This is a SBIR Program Phase I contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Zymeron Corporation, a Minority Owned Small Business. The contract is for a First Monthly Technical Report with a completion date of July 27, 2020 and a potential value of $167,494.49. Zymeron is a research-based biotechnology company that has provided medical research, engineering services, IT solutions, and innovative biotech products to federal...
- This is a firm fixed-price purchase order awarded to Zymeron Corporation, a minority-owned small business, under the Department of the Army Medical Command's Small Business Innovation Research (SBIR) program. The $250,000.00 Phase I contract is for the research and development of a "Novel Aerosol Therapy for Immediate and Sustained ARDS Management". Zymeron, a biotechnology company focused on areas like drug delivery systems, will perform this medical research at its facilities in...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The $149,933.01 firm-fixed-price contract is for research and development under the SBIR program, with a period of performance ending on January 11, 2018. Zymeron Corporation is a biotechnology company that specializes in innovative medical research...
- Zymeron Corporation has been awarded a $300,000 firm fixed price Small Business Innovation Research Program Phase I contract from the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under this contract, Zymeron will develop a novel nanoparticle delivery system to elicit a potent and long-lasting antibody response and broad neutralizing activity against HIV, as requested under the Centers for Disease Control and Prevention and NIH solicitation seeking...
- This is a $1,484,722.00 Cost Plus Fixed Fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The contract was awarded under DARPA's Small Business Innovation Research (SBIR) program, Phase II, for the development of an "Automated Partial Occlusion for Truncal Hemorrhage Control" technology. This Phase II award builds upon earlier SBIR work and is...
- Zymeron Corporation was awarded a $400,000 firm fixed price definitive contract by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to develop user-friendly technologies and devices to create an at-home Hepatitis C virus test under the Small Business Innovation Research Program Topic 441. As a small business concern, Zymeron will conduct the research and development effort at its facilities in Research Triangle Park, North Carolina through...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $300,000.00 firm-fixed-price definitive contract to Zymeron Corporation, a minority-owned small business, to provide rapid point-of-care tests to quantify hepatitis C virus. The contract has an estimated completion date of August 30, 2022 and was awarded on August 31, 2021. Zymeron is a research-based biotechnology company that develops innovative technologies...